✦ LIBER ✦

Plasminogen activator inhibitor-1 is associated with renal dysfunction independent of BMI and serum lipid levels in patients with type 2 diabetes

✍ Scribed by Jun Shirakawa; Yu Togashi; Kazuki Tajima; Kazuki Orime; Kaori Kikuchi; Takashi Miyazaki; Koichiro Sato; Mari Kimura; Yoshio Goshima; Yasuo Terauchi

Book ID: 116407480
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 202 KB
Volume: 97
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2012.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anemia is associated with an elevated se

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction

✍ Yoshimasa Aso; Ruriko Suganuma; Sadao Wakabayashi; Kenji Hara; Tomoki Nakano; Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 186 KB

1P-0067 Recurrence of myocardial infarct

1P-0067 Recurrence of myocardial infarction in strongly associated with insulin resistance and increased plasminogen activator inhibitor 1 levels both in type 2 diabetes and nondiabetic patients

✍ Lalic, N.M.; Ostojic, M.; Kanjuh, V.; Lalic, K.; Jotic, A.; Zamaklar, M.; Lukic, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Effects of gliclazide on platelet aggreg

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus

✍ Hiroyuki Konya; Yoshikazu Hasegawa; Tomoya Hamaguchi; Kahori Satani; Akiko Umeha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Association of serum levels of IGF-I and

Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus

✍ Mujde Akturk; Metin Arslan; Alev Altinova; Aysegul Ozdemir; Reyhan Ersoy; Ilhan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB

1P-0066 Severity of coronary arterial st

1P-0066 Severity of coronary arterial stenotic changes correlates with increases in plasma insulin and plasminogen activator inhibitor 1 levels in patients with type 2 diabetes

✍ Kanjuh, V.; Lalic, N.; Ostojic, M.; Lalic, K.; Beleslin, B.; Kanjuh, S.; Jotic, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Elevation of serum levels of urokinase-t

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a